Summit Therapeutics is a biotechnology company focused on developing novel medicines for serious diseases. Its core products include therapies targeting Duchenne muscular dystrophy and other rare diseases. The company operates primarily in the healthcare sector, with major revenue sources stemming from research and development collaborations, grants, and potential future product sales.
The investment profile of Summit Therapeutics is more aligned with growth investors due to its focus on innovative drug development and potential for future revenue generation. The company does not currently offer dividends, making it less suitable for dividend-focused investors. The stock may appeal to those with a medium to long-term investment horizon, given the nature of biotech development cycles.
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-11-08 | Sell | Hold | High volatility; uncertain fundamentals warrant caution. |
| 2026-10-29 | Hold | Sell | Weak fundamentals and negative momentum raise significant risk. |
| 2026-10-21 | Sell | Hold | Weak fundamentals with uncertain market conditions. |
| 2026-10-09 | Hold | Sell | Weak fundamentals and negative momentum raise significant concerns. |
| 2026-09-30 | — | Hold | Weak fundamentals and high volatility raise concerns. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-10-01 | Barclays | Target Raised | 18 → 20 | 16.91 |
| 2026-09-29 | Goldman Sachs | Update | — → 41 | 15.48 |
| 2026-09-29 | Jefferies | Target Raised | — → 30 | 15.48 |
| 2026-09-09 | Summit Redstone Partners | Rating Upgraded | — → 25 | 17.28 |
| 2026-09-08 | UBS | Update | — → 33 | 17.2748 |
| 2026-08-25 | Summit Redstone Partners | Update | — → 11.9 | 12.73 |
| 2026-07-24 | Jefferies | Target Lowered | 17 → 15 | 13.68 |
| 2026-07-24 | Stifel Nicolaus | Target Lowered | 45 → 38 | 14.98 |
| 2026-07-24 | Guggenheim | Target Lowered | 40 → 38 | 14.98 |
| 2026-05-04 | H.C. Wainwright | Target Lowered | 30 → 23 | 16.115 |
| 2026-05-01 | Piper Sandler | Target Lowered | 17 → 16 | 21.46 |
